Why the study?
Hypertension contributes to a quarter of all-cause mortality in China, prompting government aims and public health initiatives to prevent and control hypertension across the population.
Population
General population and patients with hypertension in China (estimated 270 million patients)
Design
Review
Authors
Loading...
National efforts may curb China's hypertension mortality burden; leaves open whether policies have improved control rates.
Transitioning from a high-risk population strategy to a population-wide public health approach, supported by legislation and primary healthcare, is critical for effective hypertension prevention and control in China.
Hou et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: